# Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+

> **NCT02128061** · PHASE3 · COMPLETED · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 250 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT02128061
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2018-11-05
- **Final completion:** 2021-01
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2021-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128061, "Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02128061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*